Abstract
Proteomics has become a powerful tool facilitating hypothesis-driven exploration of disease states as well as offering a global approach which can uncover potentially important, though unexpected links to disease etiology. Despite many recent advances, the pathophysiological basis of Alzheimers disease is incompletely understood. Alzheimers dementia almost certainly results from a constellation of cellular changes, with considerable interplay between multiple genetic and environmental factors. As a multifactorial disease, it is an ideal candidate for a proteomics approach which offers a broad spectrum view of changes to protein expression. The use of proteomics in the study of Alzheimers dementia is in its early days. However, its importance as an approach to the study of this disease has been recognized by a considerable number of review papers on this topic. This review summarises the advances that proteomics has so far offered to understanding the basis of Alzheimers pathology. Further, the use of proteomics to explore potential biomarkers of Alzheimers pathology which might be of clinical or diagnostic use, will be addressed.
Keywords: amyloid precursor protein (APP), MALDI-TOF, Neurofibrillary tangles, MS/MS quantification, cerebrospinal fluid (CSF), Functional Proteomics
Current Proteomics
Title: Causes and Diagnosis of Alzheimers Disease: A Proteomics Approach
Volume: 3 Issue: 2
Author(s): Anne Poljak, Perminder Sachdev and George A. Smythe
Affiliation:
Keywords: amyloid precursor protein (APP), MALDI-TOF, Neurofibrillary tangles, MS/MS quantification, cerebrospinal fluid (CSF), Functional Proteomics
Abstract: Proteomics has become a powerful tool facilitating hypothesis-driven exploration of disease states as well as offering a global approach which can uncover potentially important, though unexpected links to disease etiology. Despite many recent advances, the pathophysiological basis of Alzheimers disease is incompletely understood. Alzheimers dementia almost certainly results from a constellation of cellular changes, with considerable interplay between multiple genetic and environmental factors. As a multifactorial disease, it is an ideal candidate for a proteomics approach which offers a broad spectrum view of changes to protein expression. The use of proteomics in the study of Alzheimers dementia is in its early days. However, its importance as an approach to the study of this disease has been recognized by a considerable number of review papers on this topic. This review summarises the advances that proteomics has so far offered to understanding the basis of Alzheimers pathology. Further, the use of proteomics to explore potential biomarkers of Alzheimers pathology which might be of clinical or diagnostic use, will be addressed.
Export Options
About this article
Cite this article as:
Poljak Anne, Sachdev Perminder and Smythe A. George, Causes and Diagnosis of Alzheimers Disease: A Proteomics Approach, Current Proteomics 2006; 3 (2) . https://dx.doi.org/10.2174/157016406778194635
DOI https://dx.doi.org/10.2174/157016406778194635 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Common Variants in Toll-Like Receptor 4 Confer Susceptibility to Alzheimer’s Disease in a Han Chinese Population
Current Alzheimer Research Homocysteine and Non-Cardiac Vascular Disease
Current Pharmaceutical Design Bioinformatic Analysis Reveals Key Genes and Pathways in Aging Brain of Senescence-accelerated Mouse P8 (SAMP8)
CNS & Neurological Disorders - Drug Targets Medicinal and Beneficial Health Applications of Tinospora cordifolia (Guduchi): A Miraculous Herb Countering Various Diseases/Disorders and its Immunomodulatory Effects
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) An Overview of Valuable Scientific Models for Diabetes Mellitus
Current Diabetes Reviews Assessing Depression in Patients with an Acute Coronary Syndrome: A Literature Review
Current Psychiatry Reviews Blood-Brain Barrier P450 Enzymes and Multidrug Transporters in Drug Resistance: A Synergistic Role in Neurological Diseases
Current Drug Metabolism Antioxidant Properties and Associated Mechanisms of Salicylates
Current Medicinal Chemistry Ionotropic Glutamate Receptors & CNS Disorders
CNS & Neurological Disorders - Drug Targets Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Cardiac Effect of Cholinesterase Inhibitors Used in Alzheimers Disease - from Basic Research to Bedside
Current Alzheimer Research A Rescue Factor for Alzheimers Diseases: Discovery, Activity, Structure,and Mechanism
Current Medicinal Chemistry Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis
Current Pharmaceutical Design Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report
CNS & Neurological Disorders - Drug Targets Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimers Disease
Current Medicinal Chemistry A MicroRNA-BDNF Negative Feedback Signaling Loop in Brain: Implications for Alzheimer’s Disease
MicroRNA Metals and Parkinson's Disease: Mechanisms and Biochemical Processes
Current Medicinal Chemistry Effects and Perspectives of Chinese Patent Medicines for Tonifying <i>Qi</i> and Promoting Blood Circulation on Patients with Cerebral Infarction
Current Vascular Pharmacology